UC
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) (NCT02393248) | Incyte Corporation | 2015-02-27 |
Track UC automatically
Every clearance here is in the API, with alerts when new ones post.